StockCIK 1817241

Artiva Biotherapeutics, Inc. (ARTV): Insider Trades and Fund Holdings

In the past 12 months, Artiva Biotherapeutics, Inc. insiders reported 0 open-market purchases worth $0 and 12 sales worth $2.00M; 4 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$2.00MSold by insiders, 12 months

2Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 7, 2026.

Recent ARTV insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 7	Oct 6	Fred AslanCEO	CEO	▼ SELL10b5-1	23,463	7.20	$169K	−1.5%	Form 4 ↗
Oct 6	Oct 5	Fred AslanCEO	CEO	▼ SELL	61,696	6.84	$422K	−3.8%	Form 4 ↗
Oct 6	Oct 5	Christopher HoranChief Tech Operations Officer	Chief Tech Operations Officer	▼ SELL	10,340	6.84	$71K	−3.2%	Form 4 ↗
Oct 6	Oct 5	Jennifer BushCOO	COO	▼ SELL	8,370	6.84	$57K	−2.2%	Form 4 ↗
Oct 6	Oct 5	Subhashis BanerjeeChief Medical Officer	Chief Medical Officer	▼ SELL	1,099	6.84	$8K	−0.6%	Form 4 ↗
Sep 9	Sep 8	Fred AslanCEO	CEO	▼ SELL10b5-1	23,429	10.92	$256K	−1.6%	Form 4 ↗
Sep 4	Sep 3	Fred AslanCEO	CEO	▼ SELL	61,888	11.16	$690K	−4.0%	Form 4 ↗
Sep 4	Sep 3	Christopher HoranChief Tech Operations Officer	Chief Tech Operations Officer	▼ SELL	10,366	11.16	$116K	−3.5%	Form 4 ↗
Sep 4	Sep 3	Jennifer BushCOO	COO	▼ SELL	8,391	11.16	$94K	−2.5%	Form 4 ↗
Sep 4	Sep 3	Subhashis BanerjeeChief Medical Officer	Chief Medical Officer	▼ SELL	1,100	11.16	$12K	−0.8%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

All 12 ARTV insider trades →

Insiders who traded in the past year

Insider	Role	Bought	Sells	Sold	Latest
Fred Aslan	CEO	$0	4	$1.54M	Oct 7, 2026
Christopher Horan	Chief Tech Operations Officer	$0	2	$186K	Oct 6, 2026
Jennifer Bush	COO	$0	2	$151K	Oct 6, 2026
Subhashis Banerjee	Chief Medical Officer	$0	4	$124K	Oct 6, 2026

Tracked funds that report ARTV

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Viking Global Investors	Q2 2026	2,604,166	$25.3M	0.07%	▲ New
Renaissance Technologies	Q2 2026	151,000	$1.46M	0.00%	▲ +88.7%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →